TRBUŠEK, Martin, Jitka MALČÍKOVÁ and Jiří MAYER. Selection of new TP53 mutations by therapy in chronic lymohocytic leukemia. Leukemia Research. Elsevier, 2011, vol. 35, No 7, p. 981-982. ISSN 0145-2126.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Selection of new TP53 mutations by therapy in chronic lymohocytic leukemia
Name in Czech Selekce nových TP53 mutací terapií u CLL
Authors TRBUŠEK, Martin, Jitka MALČÍKOVÁ and Jiří MAYER.
Edition Leukemia Research, Elsevier, 2011, 0145-2126.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.923
Organization unit Central European Institute of Technology
UT WoS 000291470800044
Keywords in English TP53/p53; del(17p); mutation; selection; therapy
Tags EDITORIAL
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 13/4/2012 12:59.
Abstract
Selection of new TP53 mutations by therapy in chronic lymohocytic leukemia. Selection of new TP53 mutations by therapy in chronic lymohocytic leukemia. Selection of new TP53 mutations by therapy in chronic lymohocytic leukemia.
Abstract (in Czech)
Selekce nových TP53 mutací terapií u CLL. Selekce nových TP53 mutací terapií u CLL. Selekce nových TP53 mutací terapií u CLL. Selekce nových TP53 mutací terapií u CLL.
Links
NS9858, research and development projectName: Prognostická stratifikace CLL pacientů dle genetických změn v genu TP53 - vyhledávání mutací funkční analýzou a moderními metodami
PrintDisplayed: 9/10/2024 01:22